Pulmonary surfactant Flashcards

1
Q

When was surfactant initially identified

A

In 1920 but was not understood until the 1950’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is surfactant:

A

surface active lipoprotein complex ford by the type II alveolar cells, lines the alveoli and smallest bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When and where does surfactant production start

A

in the type II cells during terminal sac stage (17-26 weeks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When do lamellar bodies appear?

A

20 weeks gestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is alveolar surfactant broken down?

A

by macrophages and/or reabsorbed into lamellar structures of type II cells. Up to 90% of surfactant is recycled from alveolar space in the newborn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 conditions that negatively effect surfactant quality and production:

A

hyperinsulinism, acidosis, meconium aspiration (chemical pneumonitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alveolar storage pool of term infants

A

100 mg/kg of surfactant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alveolar storage pool of preterm infants

A

4-5 mg/kg of surfactant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Surfactant and compliance:

A

Increases the ability of the lungs and thorax to expand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Surfactant and surface tension:

A

Lungs are 25 d/cm and at end of expiration compressed surfactant phospholipid molecules decrease the surface tension to near 0. BY REDUCING SURFACE TENSION, FLUID FROM CAPILLARIES IS NOT DRAWN IN THE ALVEOLAR SPACES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other functions of surfactant

A

facilitates recruitment of collapsed airways, protection of the pulmonary epithelium, prevents atelectasis at the end of expiration ( INCREASES FRC). Decrease in V/Q mismatch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alveolar size contributes to what

A

As they increase the surfactant becomes distributed and expand at the same time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Primary phospholipid in surfactant

A

DPPC dipalmitoylphosphatidycholine STRONGEST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Composition of surfactant

A

40% DPPC
40% other phospholipids
5% proteins (SP-A,B,C,D) B and C in exogenous surfactants
Cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diseases related to surf deficiency

A

RDS, Congenital surfactant deficiency, pulmonary alveolar proteinosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MAS and surfactant

A

meconium inhibits surfactant function leading to alveolar collapse

17
Q

Pulmonary hemorrhage/pneumonia and surfactant

A

routine use not recommended, efficacy uncertain

18
Q

Types of surfactant

A

Synthetic: Exosurf (with or without protein)
Curosurf: porcine lung
Survanta: bovine lung
Infasurf: calf lung lavage fluid

19
Q

Evidence for re-administration of surfactant

A

for persistent or worsening RDS, low threshold for repeat dosing should be used for RDS who have perinatal depression or infection

20
Q

Pneumothorax risk with surfactant

A

decreased risk with multiple dose therapy

21
Q

How to monitor for surfactant therapy

A

ET patency and position, oxygen sats, EKG, BP, blocked airway

22
Q

Adverse effects/precautions

A

reflux up ETT, oxygen desats, pulmonary hemorrhage (2-4% of smallest pts with untreated PDA)
Post dose: hyperoxia, hypocarbia, overventilation